Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Schedule 2 products - PAAB guidelines for promotional material
-
We are marketing a Schedule 2 product (non-prescription, HC regulated) that can also be prescribed (to allow for coverage via a drug plan) and wanted to know the guidelines for branded and unbranded promotional materials when it comes to this type of Schedule 2 products.
-
We are marketing a Schedule 2 product (non-prescription, HC regulated) that can also be prescribed (to allow for coverage via a drug plan) and wanted to know the guidelines for branded and unbranded promotional materials when it comes to this type of Schedule 2 products.
Hello @ap
Schedule 2 in this case appears to be referring to NAPRA. For drug advertising, one should refer to Health Canada schedules.
Since the question was posted under the category “DTCI” we will assume you’re asking about the consumer regulations. The Food and Drug Regulations, Food and Drug Act, relation to conditions listed on Schedule A and the Health Canada document Therapeutic Comparative Advertising: Directive and Guidance Document should be applied.
For content directed to healthcare professionals, the PAAB Code applies and all aspects of the Code should be met.
